VistaGen Therapeutics
VTGN
#9179
Rank
HK$0.65 B
Marketcap
HK$22.76
Share price
2.09%
Change (1 day)
-39.61%
Change (1 year)

Revenue for VistaGen Therapeutics (VTGN)

Revenue in 2024 (TTM): HK$5.43 Million

According to VistaGen Therapeutics 's latest financial reports the company's current revenue (TTM ) is HK$5.42 Million. a decrease over the revenue in the year 2023 that were of HK$8.13 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for VistaGen Therapeutics from 2008 to 2024

Annual revenue

Year Revenue Change
2024 HK$5.42 M-33.36%
2023 HK$8.13 M-386.12%
2022 -HK$2.85 Million-124.12%
2021 HK$11.78 M134.83%
2020 HK$5.02 M
2019 N/A
2018 N/A
2013 N/A-100%
2012 HK$5.18 M-23.51%
2011 HK$6.78 M
2010 N/A
2009 N/A
2008 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA